Special Issue "The 20th Anniversary of Pharmaceuticals—Advances in Medicinal Chemistry"
Deadline for manuscript submissions: 20 December 2023 | Viewed by 3519
Interests: anticancer drug design; breast cancer; novel antioestrogens; tubulin targeting agents; azetidinones; antioestrogen–drug conjugates; oestrogen receptor; Burkitt's lymphoma; chronic lymphocytic leukaemia
Special Issues, Collections and Topics in MDPI journals
Special Issue in Pharmaceuticals: Anticancer Drugs 2021
Special Issue in Pharmaceuticals: Feature Reviews in Medicinal Chemistry
Special Issue in Pharmaceuticals: COVID-19 in Pharmaceuticals 2023
As a multidisciplinary research subject, medicinal chemistry involves topics within biology, medicine, chemistry, and covers therapeutic fields, ranging from anticancer, antiviral and antimicrobial agents to molecules potentially active in endocrine, inflammation, neurological, cardiovascular and autoimmune diseases. The numerous advances in this field, ranging from theoretical design and in silico screening to synthetic and analytical methodologies , lead discovery and optimization methods, structure-based drug design and bioinformatics are contributing to more efficient and sophisticated strategies to access therapeutic potential.
This Special Issue aims to discuss new knowledge and new cutting-edge developments related to all aspects of medicinal chemistry, which will contribute to our understanding of the relationship between molecular structure and biological activity or the mode of action of drugs. Authors are invited to contribute original research papers or reviews that report on the discovery, design, synthesis, identification and metabolism of biologically active compounds and drug candidates, together with structure–activity relationships and studies that describe investigations of the mechanism of action at the molecular level of these novel biologically active compounds.
Prof. Dr. Mary J. Meegan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug discovery
- novel drug targets
- drug discovery
- drug design and development
- synthetic methods for drugs
- analytical methodologies
- in silico screening
- structure and ligand-based drug design
- structure–activity relationships (SAR)
- drug metabolism